Trial Details
COMPLETEDBasic Information
| Clinical ID | c416 |
|---|---|
| Identifier | NCT03884439 |
| Trial Title | Infliximab Biosimilar Pfizer Drug Use Investigation (Crohn's Disease or Ulcerative Colitis) |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Crohn's Disease|Ulcerative Colitis |
| Interventions | DRUG: Infliximab [infliximab biosimilar 3] |
Participant Information
| Sponsor | Pfizer |
|---|---|
| City | Tokyo |
| Country/Region | Japan |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | CHILD, ADULT, OLDER_ADULT |
Study Design
| Study Type | OBSERVATIONAL |
|---|---|
| Phase | - |
Time Information
| Start Date | 2019-03-18 |
|---|---|
| Primary Completion Date | 2024-02-02 |
| Completion Date | 2024-02-02 |